IPD in RRMM Characterized With Genomic Abnormalities of Adverse Prognostic

Clinical trial NCT03683277 · TERMINATED

Trial details

NCT number: NCT03683277
Sponsor: Intergroupe Francophone du Myelome
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Relapsed and Refractory Multiple Myeloma Genetic Condition

Start date: 2019-11-03
Primary completion: 2022-12-31
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.